- Home
- CRBP vs FCAP Comparison
CRBP vs FCAP Comparison
Compare CRBP & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBP | FCAP |
|---|---|---|
| Founded | 2009 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.4M | 176.1M |
| IPO Year | 2014 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CRBP | FCAP |
|---|---|---|
| Price | $10.59 | $52.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $45.60 | N/A |
| AVG Volume (30 Days) | ★ 237.0K | 2.0K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | N/A | ★ 36.97 |
| EPS | N/A | ★ 4.89 |
| Revenue | $4,822,272.00 | ★ $7,170,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $116.00 | N/A |
| P/E Ratio | ★ N/A | $10.74 |
| Revenue Growth | ★ 97.62 | 1.57 |
| 52 Week Low | $6.10 | $33.88 |
| 52 Week High | $20.56 | $71.00 |
Technical Indicators
Market Signals| Indicator | CRBP | FCAP |
|---|---|---|
| Relative Strength Index (RSI) | 59.58 | 52.48 |
| Support Level | $7.91 | $49.19 |
| Resistance Level | $10.62 | $54.40 |
| Average True Range (ATR) | 0.66 | 1.51 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 63.67 | 62.52 |
Price Performance
Historical ComparisonAbout CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About FCAP First Capital Inc.
First Capital Inc is an Indiana chartered commercial bank that provides a variety of banking services to individuals and businesses. It provides retail and business banking, residential mortgage lending, real estate finance, and asset-based lending. The bank's primary source of revenue is real estate mortgage loans.